Paper · 30850331
Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.
Zhu Y and 8 others. Mol Cell, 2019. Cited by 80 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins. Papers, record 30850331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30850331
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CRISPR-Associated Protein 9 | Major topic |
| CRISPR-Cas Systems | Major topic |
| DNA | Major topic |
| Gene Editing | Major topic |
| Bacterial Proteins | |
| Humans | |
| Neisseria meningitidis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM112940 | NIGMS NIH HHS | United States | R01GM112940 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,227,035 | Preparation and Crystallization of Riboswitches. | Methods Mol Biol | 2016 | https://conductscience.org/library/papers/26227035 | PubMed |
| 2 | 26,524,520 | Conformational control of DNA target cleavage by CRISPR-Cas9. | Nature | 2015 | https://conductscience.org/library/papers/26524520 | PubMed |
| 3 | 26,317,473 | Crystal Structure of Staphylococcus aureus Cas9. | Cell | 2015 | https://conductscience.org/library/papers/26317473 | PubMed |
| 4 | 27,145,843 | CRISPR/Cas9 in Genome Editing and Beyond. | Annu Rev Biochem | 2016 | https://conductscience.org/library/papers/27145843 | PubMed |
| 5 | 26,416,740 | Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. | Nature | 2015 | https://conductscience.org/library/papers/26416740 | PubMed |
| 6 | 28,605,718 | Diversity, classification and evolution of CRISPR-Cas systems. | Curr Opin Microbiol | 2017 | https://conductscience.org/library/papers/28605718 | PubMed |
| 7 | 28,554,774 | Tubular lipid binding proteins (TULIPs) growing everywhere. | Biochim Biophys Acta Mol Cell Res | 2017 | https://conductscience.org/library/papers/28554774 | PubMed |
| 8 | 27,754,618 | Processing of X-ray diffraction data collected in oscillation mode. | Methods Enzymol | 1997 | https://conductscience.org/library/papers/27754618 | PubMed |
| 9 | 28,985,564 | Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex. | Cell | 2017 | https://conductscience.org/library/papers/28985564 | PubMed |
| 10 | 21,876,132 | Differential radial capillary action of ligand assay for high-throughput detection of protein-metabolite interactions. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21876132 | PubMed |
1 to 10 of 46
See all 46 referencesCited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,804,049 | Plant viral suppressors HcPro and P19 inhibit CRISPR-Cas13-mediated transcript interference. | Stress Biol | 2026 | https://conductscience.org/library/papers/42804049 | PubMed |
| 42,662,772 | Structural insights into Cas9 inhibition by AcrIIA17 via bridge helix interaction. | iScience | 2026 | https://conductscience.org/library/papers/42662772 | PubMed |
| 41,832,226 | AcrIIA7 hijacks tracrRNA to block CRISPR-Cas system. | Nat Commun | 2026 | https://conductscience.org/library/papers/41832226 | PubMed |
| 41,430,372 | AcrIIA19 binds to the WED domain and inhibits various Cas9 orthologs at multiple stages. | Commun Biol | 2025 | https://conductscience.org/library/papers/41430372 | PubMed |
| 41,137,484 | Investigating the molecular mechanisms underlying the anti-CRISPR function of AcrIIA13b protein. | FEBS J | 2026 | https://conductscience.org/library/papers/41137484 | PubMed |
| 40,866,699 | One-shot design of functional protein binders with BindCraft. | Nature | 2025 | https://conductscience.org/library/papers/40866699 | PubMed |
| 40,332,149 | CRISPR-Cas Systems: A Functional Perspective and Innovations. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332149 | PubMed |
| 39,940,619 | Nano-Polymers as Cas9 Inhibitors. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/39940619 | PubMed |
| 39,399,829 | Current Updates of CRISPR/Cas System and Anti-CRISPR Proteins: Innovative Applications to Improve the Genome Editing Strategies. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/39399829 | PubMed |
| 39,158,766 | Versatile plant genome engineering using anti-CRISPR-Cas12a systems. | Sci China Life Sci | 2024 | https://conductscience.org/library/papers/39158766 | PubMed |
1 to 10 of 57
See all 57 cited byGenes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATP6V0A2 | 23,545 | PubTator's text mining | https://conductscience.org/library/genes/23545 | NCBI Gene |
| IGKV2D-30 | 28,881 | PubTator's text mining | https://conductscience.org/library/genes/28881 | NCBI Gene |
| IGKV5-2 | 28,907 | PubTator's text mining | https://conductscience.org/library/genes/28907 | NCBI Gene |
| MBP | 4,155 | PubTator's text mining | https://conductscience.org/library/genes/4155 | NCBI Gene |
| NEDD9 | 4,739 | PubTator's text mining | https://conductscience.org/library/genes/4739 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30850331
GET https://conductscience.org/api/papers/v1/30850331/references?page=2